https://wikimd.com/index.php?action=history&feed=atom&title=RetrogenixRetrogenix - Revision history2026-04-21T16:23:24ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.com/index.php?title=Retrogenix&diff=5685081&oldid=prevPrab: CSV import2024-04-29T19:59:05Z<p>CSV import</p>
<p><b>New page</b></p><div>''''Retrogenix''' is a technology platform developed for the purpose of identifying the interactions between proteins and other molecules within the human cell. This innovative approach has significant implications for the fields of [[biotechnology]], [[pharmacology]], and [[molecular biology]], offering a more efficient pathway for drug discovery and the elucidation of complex biological processes. The Retrogenix technology stands out for its ability to rapidly and accurately identify the targets and off-targets of antibodies, small molecules, and other therapeutics, thereby playing a crucial role in the development of safer and more effective treatments.<br />
<br />
==Overview==<br />
The Retrogenix technology utilizes a human cell microarray to screen for interactions between a molecule of interest and over 6,000 human plasma membrane and secreted proteins. This high-throughput screening method allows for the identification of primary receptors and the mapping of cell surface interaction networks, which is essential for understanding the mechanism of action of drugs, biologics, and other therapeutic agents.<br />
<br />
==Applications==<br />
Retrogenix's cell microarray technology has a wide range of applications in the biomedical field. It is particularly useful in:<br />
<br />
* [[Drug Discovery]]: Assisting in the identification of drug targets and the assessment of drug specificity and safety.<br />
* [[Biological Research]]: Providing insights into cell signaling pathways and protein functions.<br />
* [[Safety Assessment]]: Identifying potential off-target effects of therapeutics, which is critical for drug safety.<br />
* [[Antibody Development]]: Screening for specific targets and off-targets of therapeutic antibodies.<br />
<br />
==Advantages==<br />
The Retrogenix technology offers several advantages over traditional methods of protein interaction studies, including:<br />
<br />
* High Specificity and Sensitivity: Capable of detecting even low-affinity interactions.<br />
* Broad Coverage: Screens against a wide array of human cell surface and secreted proteins.<br />
* Speed: Delivers results faster than many conventional methods, accelerating the research and development process.<br />
* Minimal Material Requirements: Requires only small amounts of the molecule of interest for screening.<br />
<br />
==Challenges==<br />
Despite its advantages, the Retrogenix technology faces challenges such as:<br />
<br />
* Limited to Human Proteins: Primarily focuses on human proteins, which may not capture interactions relevant to other species.<br />
* Cost: The advanced nature of the technology can make it more expensive than some traditional methods.<br />
<br />
==Future Directions==<br />
The ongoing development of the Retrogenix technology aims to expand its applications and improve its accessibility and efficiency. Future enhancements may include increasing the library of proteins screened to cover a more comprehensive range of cellular interactions and integrating advanced data analysis tools to better understand the complexity of protein networks.<br />
<br />
[[Category:Biotechnology]]<br />
[[Category:Pharmacology]]<br />
[[Category:Molecular Biology]]<br />
<br />
{{stub}}</div>Prab